These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2282337

  • 1. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH, Jackson HJ, Joshua SD, Burgess PM.
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [Abstract] [Full Text] [Related]

  • 2. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D, Addington J.
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [Abstract] [Full Text] [Related]

  • 3. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA, Riney SJ, Savala RA, Csernansky JG.
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [Abstract] [Full Text] [Related]

  • 4. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G, Lavrentiadis G, Amoutzias D, Monas K, Manos N.
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [Abstract] [Full Text] [Related]

  • 5. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG, Hardiker TM, Leonard DP.
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [Abstract] [Full Text] [Related]

  • 6. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R, Silk KR, Greden JF, Goodson J, Hariharan M, Meador-Woodruff JH, Kronfol Z.
    Biol Psychiatry; 1989 Mar 15; 25(6):788-92. PubMed ID: 2629711
    [No Abstract] [Full Text] [Related]

  • 7. Negative and depressive symptoms in suicidal schizophrenics.
    Jones JS, Stein DJ, Stanley B, Guido JR, Winchel R, Stanley M.
    Acta Psychiatr Scand; 1994 Feb 15; 89(2):81-7. PubMed ID: 8178667
    [Abstract] [Full Text] [Related]

  • 8. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK.
    Can J Psychiatry; 1990 Mar 15; 35(2):128-32. PubMed ID: 2138504
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone suppression test, schizophrenia and movement disorder.
    Aleem A, Kulkarni A, Yeragani VK.
    Acta Psychiatr Scand; 1988 Dec 15; 78(6):689-94. PubMed ID: 3223326
    [Abstract] [Full Text] [Related]

  • 10. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR, Weissenburger JE, Crowley GT, Khatami M, Vasavada N.
    J Clin Psychiatry; 1996 Oct 15; 57(10):470-84. PubMed ID: 8909334
    [Abstract] [Full Text] [Related]

  • 11. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J, Plocka M.
    J Affect Disord; 1992 Feb 15; 24(2):87-91. PubMed ID: 1541770
    [Abstract] [Full Text] [Related]

  • 12. The dexamethasone suppression test in schizophrenia.
    Sawyer J, Jeffries JJ.
    J Clin Psychiatry; 1984 Sep 15; 45(9):399-402. PubMed ID: 6469927
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A, Frecska E, Rihmer Z, Arató M.
    Pharmacopsychiatry; 1987 Mar 15; 20(2):48-50. PubMed ID: 3588661
    [Abstract] [Full Text] [Related]

  • 14. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA, Flegel P, Cameron OG, Greden JF.
    Psychiatry Res; 1988 Apr 15; 24(1):61-5. PubMed ID: 3393618
    [Abstract] [Full Text] [Related]

  • 15. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG.
    J Clin Psychopharmacol; 1986 Dec 15; 6(6):363-5. PubMed ID: 3805330
    [Abstract] [Full Text] [Related]

  • 16. The effect of diagnosis and age on the DST: a metaanalytic approach.
    Sharma RP, Pandey GN, Janicak PG, Peterson J, Comaty JE, Davis JM.
    Biol Psychiatry; 1988 Sep 15; 24(5):555-68. PubMed ID: 3167144
    [Abstract] [Full Text] [Related]

  • 17. The dexamethasone suppression test and residual schizophrenia.
    Harris VJ.
    Am J Psychiatry; 1985 May 15; 142(5):659-60. PubMed ID: 3985211
    [No Abstract] [Full Text] [Related]

  • 18. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S, Zander J, Garvey M.
    J Clin Psychiatry; 1984 Sep 15; 45(9):390-2. PubMed ID: 6469924
    [Abstract] [Full Text] [Related]

  • 19. The dexamethasone suppression test and negative symptoms of schizophrenia.
    McGauley GA, Aldridge CR, Fahy TA, Eastment C.
    Acta Psychiatr Scand; 1989 Dec 15; 80(6):548-53. PubMed ID: 2618777
    [Abstract] [Full Text] [Related]

  • 20. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M, De Ruyter M, Suy E.
    Psychoneuroendocrinology; 1989 Dec 15; 14(3):231-9. PubMed ID: 2756075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.